IIRM Holdings: Growth Unlocked, But Questions Remain

General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.

1. At a Glance

IIRM Holdings reported the loudest earnings number in years: net profit jumped 243% quarter-on-quarter in Q4, landing at ₹6.77 crore.

Full-year FY26 revenue crept up 15% to ₹252 crore (from ₹219 crore), net profit ticked 13% higher to ₹24.37 crore (from ₹21.63 crore).

The insurance broking business is widening margins while servicing global clients across five countries. Yet debt nearly tripled to ₹95 crore in a single year, mostly to fund an acquisition in progress — SafeRisk, a ₹85 crore bet that hasn’t closed.

The stock trades at 30.6x earnings against a peer median of 24x. The market is pricing something: either a successful SafeRisk integration, or it’s already moved ahead of the news.

2. Introduction

IIRM Holdings is a regional insurance broker, pivoted from Sudev Industries (trading outfit) three decades ago. Operations span India, Sri Lanka, Maldives, and Kenya.

Founder Vurakaranam Ramakrishna (57.5%) is chasing inorganic growth. SafeRisk acquisition (₹85 crore, announced Mar 2026) is pending IRDAI approval. To finance it, India Insure (subsidiary) raised ₹65 crore NCDs at 12% from Kotak. Ramakrishna pledged 20 million shares (29.35%) as collateral. Execution risk is live.

3. Business Model: WTF Do They Even Do?

Licensed insurance broker middleman. Sources clients, assesses risk, brokers policies, collects commission.

Three verticals (FY26): corporate broking (74%), reinsurance (13%), retail (13%). Top 10 clients = 24.5% of revenue; some 16–21 year relationships.

By product: health (15%), motor (28%), specialty (15%), fire/engineering (8%), advisory (4%), wellness (3%), other (17%).

Geography: India 93%, Sri Lanka 6%, Maldives 1%. International operations are still fledgling.

4. Financials Overview

Figures are consolidated, in ₹ crore.

Revenue growth is steady but humble—14–15% annually. But margins tell a different story. EBITDA margin expanded from 21.2% in FY25 to 23% in FY26. Operating profit margin (OPM) widened to 24.8% in Q4 from 16.4% a year ago.

That’s the broker’s game: scale clients without scaling cost. A new client onboarded in Q4 appears to have spiked both revenue and margin simultaneously.

Q4 Concall: Management guided toward 20%+ revenue and profit growth from FY26 onwards, citing three drivers: (a) SafeRisk acquisition (full-year contribution expected), (b) health insurance broking expansion (margin-accretive), (c) scale in Sri Lanka and Kenya (fledgling but intentional). No profit surprise forecast; the pivot is inorganic.

5. Market Expectations & Historical Multiples

This section describes how the market is currently pricing the company and how that compares with its own history and peer group. It is descriptive, not predictive.

At ₹109.45 (lagged reference price, not live), the market pays 30.6x FY26